Search
for
Sort by
Research 301–330 of 1000+
- Relationship between androgenic alopecia and white matter hyperintensities in apparently healthy subjects
- A Multidisciplinary Lifestyle Intervention for Women with Polycystic Ovary Syndrome: The Role of a Pulse-Based Diet and Aerobic Exercise on Reproductive, Cardio-Metabolic, and Quality of Life Outcomes
- Evaluation of Anthropometric Measurements, Arterial Stiffness and ECG Parameters in Alopecia Areata Patients
- Early onset androgenic alopecia as the male phenotypic equivalent of polycystic ovarian syndrome is associated in high oxidative stress
- Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth
- Polycystic Ovary Syndrome and NC-CAH: Distinct Characteristics and Common Findings. A Systematic Review
- Acarbose for Polycystic Ovary Syndrome
- Androgenetic Alopecia: A Review
- INFLUENCE OF LIFESTYLE ON THE PROGNOSIS OF POLYCYSTIC OVARY SYNDROME
- Male-pattern hair loss: Comprehensive identification of the associated genes as a basis for understanding pathophysiology
- Pediatric Features of Genetic Predisposition to Polycystic Ovary Syndrome
- Combination of baricitinib and conventional immunomodulating therapy for alopecia totalis
- Genetic Basis of Male Pattern Baldness
- Association of Primary Cicatricial Alopecia with Subsequent Cardiovascular Disease
- Exploring pericyte and cardiac stem cell secretome unveils new tactics for drug discovery
- Association between androgenetic alopecia and cardiovascular diseases: a genetic correlation and Mendelian randomization study
- Evaluation of Atherogenic Indexes in Patients With Lichen Planopilaris: A Case-Control Study
- No Increased Cardiovascular Hazard with Oral 5-Alpha-Reductase Inhibitors in Treatment of Androgenetic Alopecia: A TriNetX Retrospective Cohort Study
- Metabolic Syndrome, Cardiovascular Disease and the Hair Growth Cycle: Addressing hair growth disruptions using Nourkrin® with Marilex® as a proteoglycan replacement therapy: A concise review
- Cardiovascular risks and elevation of serum DHT vary by route of testosterone administration: a systematic review and meta-analysis
- Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic
- Unhealthy lifestyle and the risk of metabolic syndrome - the Romanian experience
- Cardiovascular profile of pharmacological agents used for the management of polycystic ovary syndrome
- Alopecia and cardiovascular events
- Risks for metabolic syndrome and cardiovascular diseases in both male and female patients with androgenetic alopecia
- Cardiovascular Safety and Benefits of Testosterone Implant Therapy in Postmenopausal Women: Where Are We?
- Early androgenetic alopecia as a possible indicator of diabetes mellitus and its link to cardiovascular risks: a cross-sectional study
- Metabolic Aspects of Polycystic Ovary Syndrome
- Emerging roles of Sox6 in the renal and cardiovascular system
- TERAPIA ORAL OU TÓPICA? REVISÃO INTEGRATIVA SOBRE O USO DE MINOXIDIL NA ALOPECIA ANDROGENÉTICA